Rezultati pretraživanja
  1. 1. velj

    An amazing milestone for people with ! A tremendous thanks to the pioneer study participants and families who gave so much to make this happen. Proud of faculty and staff at for contributing.

  2. prije 6 minuta

    Palforzia is a and first-of-its-kind treatment approved for use in pediatric patients, ages 4 to 17, who have been diagnosed with .

  3. Exciting news that the drug we've been testing at Manchester , AR101 has received FDA approval in the US, for children aged four to 17. We've been running trials with children & adults:

  4. prije 4 sata
  5. First ever drug approved to treat peanut allergies

  6. prije 16 sati
  7. prije 18 sati

    We also greatly appreciate the critical work by all RAMSES physician investigators and their staff – thank you for your support

    Prikaži ovu nit
  8. prije 18 sati

    Thank you to all of the PALISADE physician investigators and their staff who worked tirelessly to help get us to this approval

    Prikaži ovu nit
  9. “The FDA approval of is a milestone for people with ,” said Dr. Jacqueline Pongracic, MD, Division Head of Allergy and Immunology, who was Principal Investigator of Palforzia multicenter Phase 3 clinical trial.

    Prikaži ovu nit
  10. prije 21 sat
  11. 3. velj

    New treatment for sufferers. allergy drug approved by the US

  12. 3. velj

    The FDA has approved the first ever treatment, backing 's to reduce reactions in children

  13. 3. velj
    Odgovor korisniku/ci

    Stay away from me

  14. 3. velj

    Omg there is a new Mr. Peanut. I’m gonna die.

  15. 2. velj

    approves first drug for treatment of peanut allergy for children

  16. 2. velj
  17. 1. velj
  18. 1. velj

    Today I made some chocolate chip peanut butter cookies out of fake peanut butter that is made from soy. It actually tastes poggers, I snapped

  19. 1. velj

Čini se da učitavanje traje već neko vrijeme.

Twitter je možda preopterećen ili ima kratkotrajnih poteškoća u radu. Pokušajte ponovno ili potražite dodatne informacije u odjeljku Status Twittera.